Company intelligence / Profile preview

Yibai Technology

Ownership: Private
Development stage: Commercial

Overview

Yibai Technology is China’s leading provider of medical digital transformation services, offering a proprietary SaaS cloud platform that enables pharmaceutical companies to digitize and optimize their marketing activities. The company has served over 400 domestic and international pharmaceutical firms, including major multinationals such as Pfizer, Janssen, GSK, Sumitomo, Daiichi Sankyo, and others. Its platform supports more than 30 application scenarios ranging from online meetings and conferences to telemedicine and doctor education.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

PfizerJanssenGSKSumitomo PharmaDaiichi Sankyo

Beyond the preview

Go deeper on Yibai Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yibai Technology.

Explore the full profile